AMWL241220P1000
- 0.70
- 0.000.00%
American Well Newsroom
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
Piper Sandler Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $10
Piper Sandler Reaffirms Their Hold Rating on American Well (AMWL)
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $12 to $20
American Well Analyst Ratings
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
Truist Financial Keeps Their Hold Rating on American Well (AMWL)
TD Cowen Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $12
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $12 to $20
TD Cowen Sticks to Its Hold Rating for American Well (AMWL)
American Well (AMWL) Progresses With Caution: Hold Rating Maintained Pending Financial Outlook Confirmation
American Well Analyst Ratings
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Cogent Biosciences (COGT) and NeoGenomics (NEO)
American Well: Strategic DHA Contract Acknowledged Amid Hold Rating Pending Execution Proof
American Well: Hold Rating Amidst SaaS Deployment With DHA and Projected Financial Improvements
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
American Well (AMWL) Gets a Hold From Truist Financial
American Well Analyst Ratings
American Well: Hold Rating Affirmed Amid Cost Management Improvements and Revenue Growth Challenges
Wells Fargo Maintains American Well(AMWL.US) With Hold Rating, Cuts Target Price to $15